13/04/2025
Helix Pharma successfully convened a 𝗺𝘂𝗹𝘁𝗶𝗱𝗶𝘀𝗰𝗶𝗽𝗹𝗶𝗻𝗮𝗿𝘆 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗙𝗮𝘁𝘁𝘆 𝗟𝗶𝘃𝗲𝗿 𝗗𝗶𝘀𝗲𝗮𝘀𝗲, 𝘄𝗶𝘁𝗵 𝗽𝗮𝗿𝘁𝗶𝗰𝘂𝗹𝗮𝗿 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗽𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴 𝗿𝗼𝗹𝗲 𝗼𝗳 𝗥𝗲𝘀𝗺𝗲𝘁𝗶𝗿𝗼𝗺, bringing together esteemed KOLs from Gastroenterology, Medicine, Diabetes, Psychiatry, Neurology, Gynecology, Pediatrics, and Ophthalmology specialties to advance collaborative approaches in clinical management and public health strategies.
The event was a dynamic platform for exchanging the latest research insights, discussing challenges in early diagnosis and patient adherence, and exploring innovative therapeutic options by fostering cross-specialty dialogue.
Helix Pharma aims to strengthen the collective response to the rising burden of fatty liver disease and reinforce its commitment to supporting healthcare professionals through education, innovation, and community engagement.
𝗧𝗼𝘁𝗮𝗹 𝗴𝗮𝘁𝗵𝗲𝗿𝗶𝗻𝗴 𝗼𝗳 𝗛𝗖𝗣𝘀 𝘄𝗮𝘀 𝟵𝟵. Here are some renowned KOLs:
Professor Pervaiz Ashraf (Gastroenterologist)
Professor AmanUllah Abbasi (Gastroenterologist)
Dr. Yousaf Kamal (Consultant Physician)
Professor Sultan Mustafa (Pediatrician)
Professor Iqtidar Toufeeq (Psychiatry)
Professor Chunni Lal (Psychiatry)
Professor Razia Korejo (Gynecologist)
Dr. Fowzia Siddiqui (Neurologist)
Dr. Nazish Butt (Gastroenterologist)
Dr. Ehtisham Haider (Gastroenterologist)
Dr. Shahid Mahmood (Gastroenterologist)
Dr. Shahid Ahmed (Gastroenterologist)
